UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
July 7, 2004
ULTRALIFE BATTERIES, INC.
-----------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware
--------------------------------------------------------------
(State or other jurisdiction of incorporation or organization)
0-20852 16-1387013
- ----------------------- ------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
2000 Technology Parkway, Newark, New York 14513
---------------------------------------------------
(Address of principal executive offices) (Zip Code)
(315) 332-7100
----------------------------------------------------
(Registrant's telephone number, including area code)
1
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIALS AND EXHIBITS.
(a) Financial Statements of Business Acquired.
Not applicable.
(b) Pro Forma Financial Information.
Not applicable.
(c) Exhibits.
99.1 Press Release dated July 7, 2004
ITEM 9. REGULATION FD DISCLOSURE.
The Company today reported that it closed on a new secured credit facility,
effective June 30, 2004 totaling $25 million. This new facility is comprised of
a five-year $10 million term loan and a three-year $15 million revolving credit
facility. This agreement replaces the company's $15 million credit facility that
expired on June 30. Refer to the attached Exhibit 99.1 for the entire text of
the release, which Exhibit is being furnished but not filed in accordance with
Regulation FD.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ULTRALIFE BATTERIES, INC.
Dated: July 7, 2004 By: /s/ Peter F. Comerford
-------------------------------------
Peter F. Comerford
VP of Admin. and General Counsel
2
INDEX TO EXHIBITS
(99) ADDITIONAL EXHIBITS
99.1 Press Release dated July 7, 2004
3
Exhibit 99.1
Ultralife Batteries, Inc. Closes on New $25 Million Credit Facility
NEWARK, N.Y.--(BUSINESS WIRE)--July 7, 2004--Ultralife Batteries,
Inc. (NASDAQ: ULBI) today reported that it closed on a new secured
credit facility, effective June 30, totaling $25 million. This new
facility is comprised of a five-year $10 million term loan and a
three-year $15 million revolving credit facility. This agreement
replaces the company's $15 million credit facility that expired on
June 30.
On June 30 the company drew down the full $10 million term loan.
The proceeds of the term loan, which is to be repaid in equal
installments over five years, are to be used for the retirement of
outstanding debt and capital expenditures. Availability under the
revolving credit component is subject to various financial ratios
whereas availability under the previous facility was limited by
various asset values. The lenders of the new credit facility are JP
Morgan Chase Bank and Manufacturers and Traders Trust Company, with JP
Morgan Chase Bank acting as the administrative agent.
John Kavazanjian, president and chief executive officer, said, "We
are extremely pleased to form a financial partnership with two
well-respected financial institutions. Our improved financial
performance over the past 18 months has enabled us to obtain a
broader, more flexible credit facility than we had previously, with a
lower cost of borrowing, and based on Ultralife's financial
performance. This new arrangement provides the financial backing to
support our plans for continued growth into the future."
About Ultralife Batteries, Inc.
Ultralife is a leading developer, manufacturer, and marketer of
standard and customized lithium primary (non-rechargeable), lithium
ion and lithium polymer rechargeable batteries. Ultralife's
high-energy batteries use advanced lithium technology and are used in
military, industrial and consumer portable electronic products.
Through its range of standard products and ability to customize for a
wide range of applications, Ultralife is able to provide the next
generation of battery solutions. OEM, retail and government customers
include Energizer, Kidde Safety, Philips Medical Systems, Radio Shack
and the national defense agencies of the United States and United
Kingdom, among others.
Ultralife's headquarters, principal manufacturing and research
facilities are in Newark, New York, near Rochester. Ultralife (UK)
Ltd., a second manufacturing and research facility, is located in
Abingdon, U.K. Both facilities are ISO-9001 certified.
This press release contains forward-looking statements based on
current expectations that involve a number of risks and uncertainties.
The potential risks and uncertainties that could cause actual results
to differ materially include: loss of business with the U.S.
government, worsening global economic conditions, world events,
increased competitive environment and pricing pressures, disruptions
related to restructuring actions and delays. Further information on
these factors and other factors that could affect Ultralife's
financial results is included in Ultralife's Securities and Exchange
Commission (SEC) filings, including the latest Annual Report on Form
10-K.
Detailed information on Ultralife is available at the Company's
web site, www.ultralifebatteries.com.
CONTACT: Ultralife Batteries, Inc.
Robert W. Fishback, 315-332-7100
bfishback@ulbi.com
or
Investor Relations Contact:
Lippert/Heilshorn & Associates, Inc.
Jody Burfening, 212-838-3777
jburfening@lhai.com
or
Media Contact:
Lippert/Heilshorn & Associates, Inc.
Chenoa Taitt, 212-201-6635
ctaitt@lhai.com